ControlRad Taps Guillaume Bailliard as CEO

ControlRad Systems Names Industry Leader, Guillaume Bailliard, as CEO

Bailliard brings market development and commercial launch experience from GE Healthcare and innovative early-stage imaging companies to ControlRad Systems
PHILADELPHIA and KFAR SABA, Israel, July 13, 2015 /PRNewswire/ -- ControlRad Systems Inc., a medical device company developing innovative products that dramatically reduce damaging radiation exposure to patients and physicians during fluoroscopic procedures, announced today that industry expert Guillaume Bailliard has been named Chief Executive Officer and member of the Board of Directors. Founding CEO, Steven Nichtberger, will remain Chairman of the Board.

"Based on milestones recently achieved with the development of our products and our emerging network of partners, the Board determined that this was the right moment to implement our longstanding plan to hire an industry leader with imaging experience," said Dr. Nichtberger, Chairman of the Board. "Guillaume is an exceptionally strong leader and industry expert with relevant experience from GE Healthcare as well as early-stage companies. We are excited to welcome him to ControlRad Systems."

Mr. Bailliard has held a variety of key leadership roles in both public multi-national and private innovative companies. As a Mechanical Engineer by training, he started his career designing medical devices at Genzyme Surgical and then transitioned to GE Healthcare in a Leadership Training program. While at GE, Mr. Bailliard held various sales and management positions including in interventional fluoroscopy, ultimately responsible for the Americas X-Ray Sales operations where he restored double-digit growth. Mr. Bailliard then joined a privately held company launching an innovative imaging product in the breast cancer market, Naviscan PET Systems, followed with being appointed President of Mauna Kea Technologies Inc. introducing a disruptive imaging technology in gastroenterology, pulmonology and surgery. In these roles, Mr. Bailliard's efforts were focused on developing go-to-market strategies for disruptive technologies, building high performing teams, overcoming barriers to adoption, and growing businesses.

"I am thrilled to join ControlRad Systems at such a pivotal time. While the positive clinical impact of interventional fluoroscopy on patient care is unquestionable, the consequences of long-term ionizing radiation exposure to patients and medical staff is increasingly recognized as a concern," said Mr. Bailliard. "ControlRad Systems' innovative patented products have demonstrated the ability to dramatically reduce radiation exposure without diminishing image quality or workflow."

About ControlRad Systems
ControlRad Systems (CRS) is a medical device company developing innovative products that have the potential to dramatically reduce the risks of procedure related radiation exposure for patients, physicians, and all healthcare providers associated with fluoroscopic procedures, while maintaining if not improving image quality and workflow. This is accomplished with a propriety technology that optimizes the radiation dose to the clinically relevant region of interest while still providing important peripheral vision detail using state-of-the-art eye tracking technology to adjust in real-time high speed dynamic filters. ControlRad Systems is headquartered in greater Philadelphia and has engineering development facilities in Kfar Saba, Israel. To learn more, visit

Contact: Guillaume Bailliard
[email protected]

To view the original version on PR Newswire, visit:

SOURCE ControlRad Systems Inc.